Cue Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.About CUE
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in advancing a portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its pipeline includes CUE-221, a novel anti-IgE antibody with a dual mechanism of action, and CUE-401, designed to regulate inflammation and drive Treg-mediated tolerance.
CUE Key Statistics
Stock Snapshot
With a market cap of 134.1M, Cue Biopharma(CUE) trades at $18.60. The stock has a price-to-earnings ratio of -0.69.
During the trading session on 2026-10-15, Cue Biopharma(CUE) shares reached a daily high of $20.79 and a low of $18.09. At a current price of $18.60, the stock is +2.8% higher than the low and still -10.5% under the high.
Trading volume for Cue Biopharma(CUE) stock has reached 244.84K, versus its average volume of 215.2K.
The stock's 52-week range extends from a low of $4.97 to a high of $45.50.
The stock's 52-week range extends from a low of $4.97 to a high of $45.50.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.